These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32720296)

  • 41. Review of regulation of biological and biotechnological products in Latin American and Caribbean countries.
    Pombo ML; Di Fabio JL; Cortés Mde L
    Biologicals; 2009 Oct; 37(5):271-6. PubMed ID: 19664935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Latin American health policy and additive reform: the case of Guatemala.
    Fiedler JL
    Int J Health Serv; 1985; 15(2):275-99. PubMed ID: 3888870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review on the worldwide regulatory framework for biosimilars focusing on the Mexican case as an emerging market in Latin America.
    Ibarra-Cabrera R; Mena-Pérez SC; Bondani-Guasti A; García-Arrazola R
    Biotechnol Adv; 2013 Dec; 31(8):1333-43. PubMed ID: 23714280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advancing global health through regulatory science research: summary of the Global Summit on Regulatory Science Research and Innovation.
    Slikker W; Miller MA; Lou Valdez M; Hamburg MA
    Regul Toxicol Pharmacol; 2012 Apr; 62(3):471-3. PubMed ID: 22342950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Latin America and the Caribbean assessment.
    Viel B
    Draper Fund Rep; 1984 Jun; (13):23-5. PubMed ID: 12339635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meeting health and family planning needs in Latin America and the Caribbean.
    Popul Briefs; 1995 Jun; 1(2):4. PubMed ID: 12319543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations.
    Sáfadi MA; O'Ryan M; Valenzuela Bravo MT; Brandileone MC; Gorla MC; de Lemos AP; Moreno G; Vazquez JA; López EL; Taha MK; Borrow R;
    Vaccine; 2015 Nov; 33(48):6529-36. PubMed ID: 26597036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The urbanized societies of Latin America and the Caribbean: some dimensions and observations].
    Ebanks GE
    Notas Poblacion; 1993 Jun; 21(57):125-60. PubMed ID: 12286909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Development and evaluation of new drugs and medical devices in Japan--standpoint of regulatory agency].
    Maruyama H; Kondo T
    Brain Nerve; 2010 Mar; 62(3):263-8. PubMed ID: 20297731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
    Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
    Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Translational/regulatory science researches of NIHS for regenerative medicine and cellular therapy products].
    Sato Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):6-9. PubMed ID: 25707195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does Increased Spending on Pharmaceutical Marketing Inhibit Pioneering Innovation?
    Arnold DG; Troyer JL
    J Health Polit Policy Law; 2016 Apr; 41(2):157-79. PubMed ID: 26732315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innovation and the regulation of products of agricultural biotechnology in the United States of America.
    McCammon SL; Mendelsohn M
    Transgenic Res; 2019 Aug; 28(Suppl 2):183-186. PubMed ID: 31321703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structured pluralism: towards an innovative model for health system reform in Latin America.
    Londoño JL; Frenk J
    Health Policy; 1997 Jul; 41(1):1-36. PubMed ID: 10169060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An overview of health-related industrial biotechnology in Latin America and the Caribbean.
    Marques MB
    Bull Pan Am Health Organ; 1996 Jun; 30(2):95-105. PubMed ID: 8704761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Condoms becoming more popular.
    Manuel J
    Netw Res Triangle Park N C; 1993 May; 13(4):22-4. PubMed ID: 12344872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New Governmental Regulatory System for Stem Cell-Based Therapies in Japan.
    Hara A; Sato D; Sahara Y
    Ther Innov Regul Sci; 2014 Nov; 48(6):681-688. PubMed ID: 30227468
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.